General form of registration statement for all companies including face-amount certificate companies

Consolidated Balance Sheets

v2.4.0.8
Consolidated Balance Sheets (USD $)
Sep. 30, 2013
Dec. 31, 2012
Dec. 31, 2011
Current Assets:      
Cash and cash equivalents $ 3,990,063 $ 5,618,669 $ 5,703,798
R&D reimbursement receivable       237,834
Prepaid expenses and other current assets 53,000 167,143 5,384
Deferred financing costs, net of accumulated amortization       252,248
Total Current Assets 4,043,063 5,785,812 6,199,264
Property and equipment, net of accumulated depreciation 6,918 3,010 1,233
Total Assets 4,049,981 5,788,822 6,200,497
Current Liabilities:      
Accounts payable and accrued expenses 312,001 897,044 644,511
Accounts payable and accrued expenses - related party 375,686 31,185   
Note payable    140,000   
Convertible notes payable, net of unamortized discount       124,363
Derivative liabilities 2,757,966 3,574,958 4,439,613
Total Current Liabilities 3,445,653 4,643,187 5,208,487
Total Liabilities 3,445,653 4,643,187  
Commitments and contingencies         
Stockholders' Equity:      
Preferred stock value         
Common stock value 23,657 21,392 136,648
Additional paid in capital 61,218,085 56,867,706 48,237,620
Deficit accumulated during the development stage (60,637,414) (55,743,463) (47,382,258)
Total Stockholders' Equity 604,328 1,145,635 992,010
Total Liabilities and Stockholders' Equity $ 4,049,981 $ 5,788,822 $ 6,200,497